- Home
- SQNS vs ARMP Comparison
SQNS vs ARMP Comparison
Compare SQNS & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- ARMP
- Stock Information
- Founded
- SQNS 2003
- ARMP N/A
- Country
- SQNS France
- ARMP United States
- Employees
- SQNS N/A
- ARMP N/A
- Industry
- SQNS Semiconductors
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SQNS Technology
- ARMP Health Care
- Exchange
- SQNS Nasdaq
- ARMP Nasdaq
- Market Cap
- SQNS 46.5M
- ARMP 52.1M
- IPO Year
- SQNS 2011
- ARMP N/A
- Fundamental
- Price
- SQNS $1.86
- ARMP $1.96
- Analyst Decision
- SQNS Strong Buy
- ARMP Strong Buy
- Analyst Count
- SQNS 1
- ARMP 1
- Target Price
- SQNS $7.50
- ARMP $9.00
- AVG Volume (30 Days)
- SQNS 48.5K
- ARMP 625.4K
- Earning Date
- SQNS 05-06-2025
- ARMP 05-14-2025
- Dividend Yield
- SQNS N/A
- ARMP N/A
- EPS Growth
- SQNS N/A
- ARMP N/A
- EPS
- SQNS 2.16
- ARMP N/A
- Revenue
- SQNS $38,858,000.00
- ARMP $4,699,000.00
- Revenue This Year
- SQNS N/A
- ARMP $8.43
- Revenue Next Year
- SQNS $93.87
- ARMP N/A
- P/E Ratio
- SQNS $0.87
- ARMP N/A
- Revenue Growth
- SQNS 40.06
- ARMP 14.24
- 52 Week Low
- SQNS $0.95
- ARMP $0.90
- 52 Week High
- SQNS $4.28
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- SQNS 51.47
- ARMP 56.48
- Support Level
- SQNS $1.72
- ARMP $1.90
- Resistance Level
- SQNS $1.85
- ARMP $2.04
- Average True Range (ATR)
- SQNS 0.08
- ARMP 0.23
- MACD
- SQNS 0.02
- ARMP -0.01
- Stochastic Oscillator
- SQNS 56.00
- ARMP 22.45
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.